About Me
Conditions and Treatments
Learn more about conditions we treat at NYU Langone:
Autonomic Disorders, Parkinson’s Disease, Familial DysautonomiaCredentials
Positions
- Associate Professor, Department of Neurology
- Pillar Director, Neurodegenerative Disease
- Assistant Director, Dysautonomia Research Laboratory
Education and Training
- Fellowship, NYU School of Medicine, Neurology, 2015
- PhD from University Of Navarra, 2013
- Residency, Universidad de Navarra Facultad de Medicina, Neurology, 2012
- MD from University Of Navarra, 2007
Departments
Is this your profile?
Edit profileIs this your profile?
Edit profileLocations and Appointments
- Medicare
Dysautonomia Center
530 First Avenue, Suite 9Q
New York, NY 10016
Research My Research
Interests
clinical trials, multiple system atrophy, autonomic failure, orthostatic hypotension, hereditary sensory and autonomic neuropathy, familial dysautonomia, autonomic autoimmune ganglionopathy, autonomic disorders
Research Summary
Dr. Palma's work over the past years has focused on the description of the autonomic phenotype and the search for biomarkers in patients with neurodegenerative autonomic disorders, including multiple system atrophy (MSA), Parkinson disease (PD) and pure autonomic failure (PAF).
Dr. Palma is one of the international coordinators of the Natural History Study of the Synucleinopathies. He is the principal or co-investigator in clinical trials for neurogenic orthostatic hypotension and multiple system atrophy as well as in the development of biomarkers of disease diagnosis and progression.
His work in rare diseases is also focused on genetic autonomic disorders. Dr. Palma is interested in defining the phenotype and genotype of and clinical trial design and conduct for familial dysautonomia (Riley-Day syndrome) and other rare hereditary sensory autonomic neuropathies (HSAN).
Academic Contact
Academic office
530 First Avenue
Ninth Floor
New York, NY 10016
Research Interests Timeline
Clinical Trials and Research Studies
-
Learn More
A Phase 3 22-week Multi-center Randomized Withdrawal Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects with Primary Autonomic Failure
-
Learn More
A Phase 3 4-week Multicenter Randomized Double-blind Placebo-controlled Parallel-group Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure
-
Learn More
A futility trial of sirolimus in multiple system atrophy
Publications
-
Palma, Jose-Alberto; Gileles-Hillel, Alex; Norcliffe-Kaufmann, Lucy; Kaufmann, Horacio
Autonomic neuroscience. 2019 May ; 218:10-15
-
Stankovic, Iva; Quinn, Niall; Vignatelli, Luca; Antonini, Angelo; Berg, Daniela; Coon, Elizabeth; Cortelli, Pietro; Fanciulli, Alessandra; Ferreira, Joaquim J; Freeman, Roy; Halliday, Glenda; Höglinger, Günter U; Iodice, Valeria; Kaufmann, Horacio; Klockgether, Thomas; Kostic, Vladimir; Krismer, Florian; Lang, Anthony; Levin, Johannes; Low, Phillip; Mathias, Christopher; Meissner, Wassillios G; Kaufmann, Lucy Norcliffe; Palma, Jose-Alberto; Panicker, Jalesh N; Pellecchia, Maria Teresa; Sakakibara, Ryuji; Schmahmann, Jeremy; Scholz, Sonja W; Singer, Wolfgang; Stamelou, Maria; Tolosa, Eduardo; Tsuji, Shoji; Seppi, Klaus; Poewe, Werner; Wenning, Gregor K
Movement disorders. 2019 Apr 29;
-
Kaufmann, Horacio; Norcliffe-Kaufmann, Lucy; Palma, Jose-Alberto
Clinical autonomic research. 2019 Apr ; 29(2):255-256